What's breaking now, across thousands of outlets.
The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
British Columbia's human rights tribunal found LifeLabs and its subsidiary Excelleris Technologies misgendered and outed three patients at clinics in Vancouver and Burnaby in 2019.
British Columbia's human rights tribunal found LifeLabs and its subsidiary Excelleris Technologies misgendered and outed three patients at clinics in Vancouver and Burnaby in 2019.
A pioneering study in the Eastern Cape demonstrates how peer-led recovery groups can sharply curb psychosis relapses and keep schizophrenia patients out of hospital, yet deep poverty poses a lasting…
[Leadership] Kogi State governor, Alhaji Ahmed Usman Ododo, has flagged off the 2026 Insecticide-Treated Nets (ITNs) Mass Distribution Campaign, targeting 3,810,985 mosquito nets for 1,130,935…
An event that changed us in so many ways. Don't miss a story, subscribe here.
Marea Therapeutics' investigational lipid-lowering medicine has shown further promise in cutting triglycerides in patients with dangerously high levels of these fatty molecules in their blood.
